Medical Microinstruments, Inc. (MMI) is a fast-growing surgical robotics company that develops and commercializes robotic-assisted microsurgery systems. Their flagship product, the Symani Surgical System, features the world's smallest wristed instruments and is designed for robotic-assisted microsurgery and supermicrosurgery.

Giuseppe Prisco

Hannah Teichmann

Massimiliano Simi

Medical Microinstruments, Inc. (MMI)

A developer of novel robotic solutions for unmet medical needs for microsurgery.

MMI has developed the first teleoperated robotic platform for suturing in open surgery with wristed microinstruments. It offers the surgeon motion scaling and tremor elimination and aims to facilitate existing procedures as well as enable new ones in the domain of microsurgery, from post-oncological and trauma reconstructions to ophthalmology, organ transplantation and pediatric surgery. 

The Company’s mission is to help more surgeons around the world to offer more advanced procedures, while reducing costs for patients, hospitals and for society at large.

Panakes Partners

Andera Partners

Fountain Healthcare Partners

BioStar Capital

Samba Tech

RA Capital Management

Deerfield

Fidelity

Medical Microinstruments, Inc.

The next great breakthrough in microsurgery is now available in the U.S.! The FDA has authorized the Symani Surgical System for commercial use. This game-changing, robotic technology increases patient access to advanced techniques for surgeries in complex disease states and provides surgeons with enhanced precision and control.   

Learn more about the first microsurgical robotic platform available in the U.S.: https://lnkd.in/ehxdQgVc

#Symani #microsurgery #robotics 

Surgeons have leveraged the Symani Surgical System in countless clinical cases in the European Union and in many preclinical cases around the world. To learn more about some of the research that’s been performed using the system, visit our website: https://ow.ly/Tbt050R7lpo

#roboticsurgery #microsurgery

The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S.

As Lymphedema Awareness Month comes to a close, we remain proud to support Lymphatic Education & Research Network and its vital mission to fight lymphatic diseases through education, research and advocacy. For patients suffering from lymphatic diseases, LE&RN’s online resource center offers valuable insights into treatment options and specialized #lymphatic centers. We’re excited to partner with LE&RN to continue to raise awareness and support for lymphatic diseases. 

Learn more:  https://lnkd.in/g92Qy5xE

Thank you to Italian Tech Alliance for conducting a study – and including MMI – about the positive impact startup companies are having on local employment growth. We're honored Deborah Lo Conti, Sr. HR Generalist, was invited to participate in yesterday's panel discussion. We are proud to support job creation in our communities!

We believe that all patients deserve the most innovative, open surgical treatment options so they can live their fullest lives. Learn more about our mission to advance robotic technology that pushes the limits of soft tissue open surgery and opens new opportunities for surgeons to restore the quality of life for patients with complex conditions: https://lnkd.in/ezR8AxjV
 
#robotics #microsurgery #Symani
 
The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S. 

Metric
Company Name	Medical Microinstruments, Inc. (MMI)
Symbol
MSH ID	COM:MMIMICRO
Market	PRIVATE
Sector	Capital Goods & Industrials
Industry	Medical Devices
Country	IT
Stage
Employee Count	222
Website	mmimicro.com
LinkedIn	mmimicro
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:MMIMICRO

Medical Microinstruments, Inc. (MMI)

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue